COVID-19: Joint development with HORIBA antibody test chip: Immunoassay in a minimum of 15 minutes
COVID-19:
June 23, 2020
HORIBA:
We will promote joint development with the National Institute of Advanced Industrial Science and Technology.
Participate in AIST’s simple and rapid antibody test chip system development.
HORIBA has cultivated over many years,
Deep knowledge of immunoassay *1,
Specimen inspection *2 Utilizing our strengths in technology,
We will work to achieve early development.
Development of virus infection control technology:
It will be implemented as part of “Development of a reliable and rapid diagnostic system for the new coronavirus”.
Antibodies for new coronavirus:
For the COVID-19 antibody test, it is required to establish a method that enables simple, quick and accurate tests.
AIST:
We have established an “immunoassay method that enables highly accurate tests in as little as 15 minutes simply by dropping blood or reagents on a microchip”.
This time, using this technology, we will proceed with the development of a system adapted to the antibody test for new coronavirus.
Role of HORIBA:
In cooperation with AIST and Bizgene Co., Ltd., we aim to develop a fully automatic measuring device.
HORIBA
https://www.horiba.com/jp/corporate-news/news/article/65807/